|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.Switzerland |
First Approval Date28 Jun 1984 |
/ Not yet recruitingPhase 4 Glycemic Control with Triple Pathway Approach Through Empagliflozin-Linagliptin-Metformin
The efficacy and safety of a triple-pill combination therapy for advanced type 2 diabetes care. The study aims to assess the impact of 3 Oral Anti Diabetic (OAD) drugs on metabolic control, patient compliance, weight management, quality of life, diabetic treatment satisfaction and frequency of hypoglycemic events by combining them into a fixed-dose single pill.
Misoprostol for Non-alcoholic Steatohepatitis- a Randomized Control Trial
The aim of this randomised control trial is to evaluate the effect of Misoprostol in treating patients with NASH.
Efficacy and Safety Study of Fixed Dose Combination Tablet of Iron Polymaltose and Folic Acid (Tablet Irpo- FA®) in Pregnant Women with Iron Deficiency Anaemia.
100 Clinical Results associated with Nabiqasim Industries (Pvt) Ltd
0 Patents (Medical) associated with Nabiqasim Industries (Pvt) Ltd
100 Deals associated with Nabiqasim Industries (Pvt) Ltd
100 Translational Medicine associated with Nabiqasim Industries (Pvt) Ltd